Jubilant, Amgen Enter Drug Discovery Deal

Jubilant Biosys Ltd. (Bangalore, India), a subsidiary of Jubilant Organosys (Noida), says it has entered into a drug discovery partnership with biotechnology firm Amgen (Thousand Oaks, CA). The companies will collaborate to develop a novel drug portfolio across multiple therapeutic areas, Jubilant says. The agreement calls for Jubilant to develop early preclinical candidates from Amgen’s early discovery efforts, for an initial term of three years. Amgen will have responsibility for subsequent preclinical and clinical development and commercialization and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers